We recently published a list of Jim Cramer Discussed These 29 Stocks Ahead Of Major AI Event. In this article, we are going ...

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...

Shares of Merck & Co. Inc. MRK sank 0.60% to $99.25 Friday, on what proved to be an all-around rough trading session for the ...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows ...

Merck & Co Inc (MRK) stock saw a decline, ending the day at $99.85 which represents a decrease of $-1.17 or -1.16% from the prior close of $101.02. The stock opened at $100.7 and touched a low of $98.

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).

Drugmakers have greeted 2025, implementing price hikes for 583 products within the first two days of the new year, according ...

Truist downgraded Merck (MRK) to Hold from Buy with a price target of $110, down from $130, as part of a broader research note previewing FY25 ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of ...

Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...